亚太药业：2025年前三季度净利润约9720万元

Group 1 - Company reported Q3 performance with revenue of approximately 228 million yuan, a year-on-year decrease of 25.59% [1] - Net profit attributable to shareholders was approximately 97.2 million yuan, a year-on-year increase of 2909.49% [1] - Basic earnings per share increased to 0.1313 yuan, a year-on-year increase of 2444.64% [1] Group 2 - As of the report, the market capitalization of the company is 5.3 billion yuan [2]